Antiplatelet and anticoagulant agents are treatment mainstays, and pharmacists play a role in educating and monitoring at-risk patients on pharmacologic as well as nonpharmacologic interventions.
This condition’s inflammatory responses mimic peripheral neuropathy and peripheral vascular disease, potentially resulting in delayed diagnosis and management.
Ischemic heart disease remains the leading cause of cardiovascular disease (CVD) mortality worldwide, with an age-standardized rate per 100,000 of 108.8 deaths.